Association between green tea/coffee consumption and biliary tract cancer: A population-based cohort study in Japan

Cancer Science

Volumn 107, Issue 1, 2016, Pages 76-83

  Makiuchi, Takeshi ^a   Sobue, Tomotaka ^a   Kitamura, Tetsuhisa ^a   Ishihara, Junko ^b   Sawada, Norie ^c   Iwasaki, Motoki ^c   Sasazuki, Shizuka ^c   Yamaji, Taiki ^c   Shimazu, Taichi ^c   Tsugane, Shoichiro ^c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

Author keywords

Biliary tract cancer; Coffee; Cohort; Green tea; Prospective study

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILIARY TRACT CANCER; CANCER INCIDENCE; CANCER RISK; COFFEE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; TEA; BILIARY TRACT NEOPLASMS; DIET; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE;

COFFEE; TEA;

AGED; BILIARY TRACT NEOPLASMS; COFFEE; COHORT STUDIES; DIET; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TEA;

EID: 84956716594     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12843     Document Type: Article

References (44)

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86.
2. Tsaitas C, Semertzidou A, Sinakos E. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol 2014; 6: 178-87.
3. Tashiro S, Imaizumi T, Ohkawa H et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg 2003; 10: 345-51.
4. Ishiguro S, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Causes Control 2008; 19: 33-41.
5. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006; 27: 1301-09.
6. Clark J, You M. Chemoprevention of lung cancer by tea. Mol Nutr Food Res 2006; 50: 144-51.
7. Hoshiyama Y, Kawaguchi T, Miura Y et al. Green tea and stomach cancer - a short review of prospective studies. J Epidemiol 2006; 15(Suppl 2): S109-12.
8. Cheng KK, Day NE. Nutrition and esophageal cancer. Cancer Causes Control 1996; 7: 33-40.
9. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 2006; 27: 1310-15.
10. Saleem M, Adhami VM, Siddiqui IA, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer 2003; 47: 13-23.
11. Ju J, Lu G, Lambert JD, Yang CS. Inhibition of carcinogenesis by tea constituents. Semin Cancer Biol 2007; 17: 395-402.
12. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009; 9: 429-39.
13. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003; 43: 89-143.
14. Nkondjock A. Coffee consumption and the risk of cancer: an overview. Cancer Lett 2009; 277: 121-25.
15. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S; Japan Public Health Center (JPHC) Study Group. Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 2009; 100: 294-91.
16. Zatonski WA, La Vecchia C, Przewozniak K, Maisonneuve P, Lowenfels AB, Boyle P. Risk factors for gallbladder cancer: a Polish case-control study. Int J Cancer 1992; 51: 707-11.
17. Zhang XH, Andreotti G, Gao YT et al. Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China. Int J Cancer 2006; 118: 3089-94.
18. Jain K, Sreenivas V, Velpandian T, Kapil U, Garg PK. Risk factors for gallbladder cancer: a case-control study. Int J Cancer 2013; 132: 1660-66.
19. Ghadirian P, Simard A, Baillargeon J. A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada. Rev Epidemiol Sante Publique 1993; 41: 107-12.
20. Kato K, Akai S, Tominaga S, Kato I. A case-control study of biliary tract cancer in Niigata Prefecture, Japan. Cancer Sci 1989; 80: 932-38.
21. Nechuta S, Shu XO, Li HL et al. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr 2012; 96: 1056-63.
22. Pandey M, Shukla VK. Diet and gallbladder cancer: a case-control study. Eur J Cancer Prev 2002; 11: 365-68.
23. Yen S, Hsieh CC, MacMahon B. Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral-contraceptive use. Cancer 1987; 59: 2112-16.
24. Takada M, Ku Y, Habara K, Ajiki T, Suzuki Y, Kuroda Y. Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg 2002; 26: 683-86.
25. Lang M, Henson R, Braconi C, Patel T. Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. Liver Int 2009; 29: 670-77.
26. Senggunprai L, Kukongviriyapan V, Prawan A, Kukongviriyapan U. Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway. Phytother Res 2014; 28: 841-48.
27. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea - a review. J Am Coll Nutr 2006; 25: 79-99.
28. Tsugane S, Sawada N. The JPHC study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol 2014; 44: 777-82.
29. Iwasaki M, Inoue M, Sasazuki S et al. Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res 2010; 12: R88.
30. Nanri A, Shimazu T, Ishihara J et al. Reproducibility and validity of dietary patterns assessed by a food frequency questionnaire used in the 5-year follow-up survey of the Japan Public Health Center-Based Prospective Study. J Epidemiol 2012; 22: 205-15.
31. Willett WC. Nutritional Epidemiology, 2nd edn. New York, NY: Oxford University Press, 1998.
32. Thawonsuwan J, Kiron V, Satoh S, Panigrahi A, Verlhac V. Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss. Fish Physiol Biochem 2010; 36: 687-97.
33. Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011; 82: 1807-21.
34. Shan D, Fang Y, Ye Y, Liu J. EGCG reducing the susceptibility to cholesterol gallstone formation through the regulation of inflammation. Biomed Pharmacother 2008; 62: 677-83.
35. Block G. Epidemiologic evidence regarding vitamin C and cancer. Am J Clin Nutr 1991; 54(6 Suppl): 1310S-14S.
36. Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology 2015; 148: 1244-60.e16.
37. Panda D, Sharma A, Shukla NK et al. Gall bladder cancer and the role of dietary and lifestyle factors: a case-control study in a North Indian population. Eur J Cancer Prev 2013; 22: 431-37.
38. The Council for Science and Technology, Ministry of Education, Culture, Sports, Science and Technology, Japan: Standard Tables of Food Composition in Japan -2010-. Tokyo: National Printing Bureau, 2010.
39. Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006; 27: 269-77.
40. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001; 20: 1803-15.
41. Efferth T, Fabry U, Glatte P, Osieka R. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol 1995; 121: 648-56.
42. Zhou Y, Tian C, Jia C. A dose-response meta-analysis of coffee consumption and bladder cancer. Prev Med 2012; 55: 14-22.
43. Villanueva CM, Silverman DT, Murta-Nascimento C et al. Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control 2009; 20: 121-27.
44. Douglas BR, Jansen JB, Tham RT, Lamers CB. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. Am J Clin Nutr 1990; 52: 553-56.